ARK Israel Innovative Technology ETF Stock Forecast, Price & News

ARK Israel Innovative Technology ETF's stock was trading at $18.2080 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, IZRL shares have increased by 84.5% and is now trading at $33.60.
View which stocks have been most impacted by COVID-19.

Wall Street analysts have given ARK Israel Innovative Technology ETF a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but ARK Israel Innovative Technology ETF wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Based on aggregate information from My MarketBeat watchlists, some companies that other ARK Israel Innovative Technology ETF investors own include ARK Genomic Revolution ETF (ARKG), ARK Innovation ETF (ARKK), Ares Capital (ARCC), ARK Fintech Innovation ETF (ARKF), ARK Next Generation Internet ETF (ARKW), Magellan Midstream Partners (MMP), Medical Properties Trust (MPW), Omega Healthcare Investors (OHI), The Southern (SO) and Brookfield Infrastructure Partners (BIP).

ARK Israel Innovative Technology ETF trades on the BATS under the ticker symbol "IZRL."

Shares of IZRL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of IZRL stock can currently be purchased for approximately $33.60.